- Motley Fool•yesterday
Cancer drug costs routinely eclipse the six-figure mark, but the prices of these cancer drugs are truly eye-popping.
- Accesswire•yesterdayIMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Seattle Genetics, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 23, 2017 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against Seattle Genetics, Inc. ("Seattle Genetics" or the "Company") ...
- GlobeNewswire•yesterdayLawsuit for Investors in shares of Seattle Genetics, Inc. (NASDAQ:SGEN) announced by Shareholders Foundation
SAN DIEGO, Jan. 23, 2017-- The Shareholders Foundation, Inc. announces that a lawsuit was filed in Washington on behalf of certain purchasers of shares of Seattle Genetics, Inc. over alleged Securities ...
SGEN : Summary for Seattle Genetics, Inc. - Yahoo Finance
Seattle Genetics, Inc. (SGEN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||53.14 x 100|
|Ask||65.00 x 500|
|Day's Range||57.30 - 59.08|
|52 Week Range||26.02 - 75.36|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-74.15|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|